P2X3 receptor antagonists for treatment of pain
US9238647B2 · kind B2 · utility
4Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 15, 2010 |
| Grant date | Jan 19, 2016 |
| Priority date | — |
| Expiry date | Nov 11, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The subject invention relates to novel P2X3 receptor antagonists that play a critical role in treating disease states associated with pain, in particular peripheral pain, inflammatory pain, or tissue injury pain that can be treated using a P2X3 receptor subunit modulator.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.